In an attempt to assess the structural requirements for the muscarinic receptor selectivity of hexahydro-diphenidol (hexahydro-difenidol) and hexahydro-sila-diphenidol (hexahydro-sila-difenidol), a series of structurally related C/Si pairs were investigated, along with atropine, pirenzepine and methoctramine, for their binding affinities in NB-OK 1 cells as well as in rat heart and pancreas.
Introduction
Three muscarinic receptors with different selectivities for antagonists have been described in binding studies as well as in in vitro and in vivo pharmacological assays. M1 receptors are above all found in the nervous system and are characterized by a high affinity for pirenzepine Birdsall et al., 1980; Brown et al., 1980; Hammer & Giachetti, 1982; Lambrecht et al., 1988b) . M2 receptors, which show low affinity for pirenzepine, have been further subdivided into cardiac type and glandular/ smooth muscle subtypes by use of selective antago-1 Author for correspondence. nists such as 4-diphenylacetoxy-N-methyl-piperidine methiodide (4-DAMP) (Barlow et al., 1976; Waelbroeck et al., 1987a; Doods et al., 1987) , hexahydrodiphenidol (hexahydro-difenidol) and hexahydro-sila-diphenidol (hexahydro-sila-difenidol) (Mutschler & Lambrecht, 1984; Waelbroeck et al., 1987b; Lambrecht et al., 1988a, c) , AF-DX 116 (Hammer et al., 1986; Giachetti et al., 1986; Doods et al., 1987) and methoctramine (Melchiorre et al., 1987; Michel & Whiting, 1988) .
Among these selective muscarinic antagonists, hexahydro-diphenidol (3a) and hexahydro-sila-diphenidol (3b) have been shown to for M1 receptors in neuronal tissues as well as for glandular/smooth muscle receptors in exocrine glands and smooth muscle, but a much lower affinity for cardiac receptors (Mutschler & Lambrecht, 1984; Waelbroeck et al., 1987b; Lambrecht et al., 1988a,c) . In order to assess the structural requirements for the observed selectivity of 3a/3b, the binding characteristics of a series of C/Si pairs structurally related to 3a/3b were determined (compounds la/lb, 2a/2b, 4a/ 4b-6a/6b; Figure 1) . These experiments were carried out using a NB-OK 1 cell line (M1 receptors type) and rat heart (cardiac receptors type) and pancreas (glandular/smooth muscle receptors type) homogenates (Waelbroeck et al., 1987a,b,c) . Furthermore the binding affinities of compounds la/lb-6a/6b to glandular/smooth muscle and cardiac receptor types were compared with the functional antimuscarinic properties in guinea-pig isolated ileum and atria. Atropine, pirenzepine and methoctramine were used as reference drugs.
The experiments were carried out using the racemates of compounds la/lb to 6a/6b but some data of functional experiments with the individual enantiomers of Sa/5b and 6a/6b have been published elsewhere and binding studies are in progress.
Methods

Radioligand binding studies
Tissue preparations Male Wistar rats (200-250g) were killed by decapitation and the pancreas and heart were immediately removed.
The pancreas was minced with scissors and homogenized in 8 ml per pancreas of 300 mm sucrose enriched with 0.2mgmlP1 bacitracin and 500 kallikrein inhibitor unitsml-1 of aprotinin, with a glass-Teflon homogenizer (7 up and down strokes). The resulting homogenate was filtered on two layers of medical gauze, and immediately diluted 11 fold with the incubation buffer (66 mm sodium phosphate buffer (pH 7.4) enriched with 2.6mm MgCl2 and with 1.32% bovine serum albumin, 0.24mgml-' bacitracin and 600 kallikrein inhibitor units ml' aprotinin).
The hearts were rinsed in isotonic NaCI, then homogenized in 2.5ml of Tris-HCI buffer (pH 7.5) enriched with 250 mm sucrose, in an Ultraturrax homogenizer (5 s at maximum setting). The resulting homogenate was diluted 8 fold with the same buffer and filtered on two layers of medical gauze.
NB-OK 1 cells were cultured in RPMI 1640 medium, enriched with 10% foetal calf serum, 100 unitsml-1 penicillin and 100pgmlPl streptomycin, as described previously (Waelbroeck et al., 1988) .
ing experiments, the cells were rinsed, detached and centrifuged in 20 mm sodium phosphate buffer (pH 7.4) containing 156 mm NaCl and 1 mm EDTA, resuspended and homogenized in 20mm Tris-HCI buffer (pH 7.5) enriched with 5 mM MgCI2 and stored in liquid nitrogen.
Binding experiments: On rat pancreas homogenates, 1 ml of diluted homogenate (800 to 1000 ug protein per assay) was added to 200 M1 of [3H]-NMS and unlabelled drugs (in water) to obtain final concentrations of 50 mm sodium phosphate buffer (pH 7.4), 2 mM MgCl2, 1% bovine serum albumin, 0.2mg ml1 bacitracin and 500 kallikrein inhibitor units ml-' of aprotinin. The [3H]-NMS concentration was 240pM (with a KD value of 120 PM in pancreas). This incubation was prolonged for 4 h at 25°C to allow equilibration of tracer binding to pancreas receptors (Waelbroeck et al., 1987b) .
On rat cardiac homogenates, 80 p1 of homogenate (400 to 500jug of protein) was used per assay, in a total volume of 1.2 ml containing (final concentrations): 50 mM sodium phosphate buffer (pH 7.4), 2 mm MgCl2, 1% bovine serum albumin, and the indicated concentrations of [3H]-NMS, and unlabelled drugs. The [3H]-NMS concentration was 1.0 nM (with a KD value of 0.5 nm in heart). The incubation period was 2 h at 25°C, sufficient to allow equilibrium binding of [3H]-NMS in this tissue (Waelbroeck et al., 1987a,b) .
On human NB-OK I homogenates, 80yl of homogenate (80 pg of protein) was used per assay, in a total volume of 1.2 ml containing (final concentrations): 50 mm sodium phosphate buffer (pH 7.4), 2 mm MgCl2, 1% bovine serum albumin, and the indicated concentrations of [3H]-NMS, and unlabelled drugs. The [3H]-NMS concentration was 240 pM (with a KD value of 120 pM in NB-OK 1 homogenates). An incubation period of 2 h at 25°C was sufficient to allow equilibrium binding of [3H]-NMS in this tissue (Waelbroeck et al., 1988) .
Non-specific [3H]-NMS binding, using pancreas, heart and NB-OK 1 homogenates was defined as [3H]-NMS binding in the presence of 1 pM atropine. In our binding conditions, non-specific binding represented less than 5% of total tracer binding, and was fully accounted for by binding to GF/C glassfibre filters (see below).
To separate bound and free [3H]-NMS, in pancreas, heart or NB-OK 1 homogenates, 2ml of icecold 50mM sodium phosphate buffer (pH 7.4) was added to each sample, followed by immediate filtration on GF/C glass-fibre filters (Whatman, Maidstone, Kent, England) presoaked overnight in 0.05% polyethyleneimine. The filters were rinsed three times with the same phosphate buffer, dried, and the radioactivity counted by liquid scintillation.
Analysis of binding data All competition curves were repeated at least three times, in duplicate. IC50 values were determined by a computer-aided procedure described by Richardson & Humrich (1984) , assuming the existence of only one receptor subtype. Experimental data points were within 3% of the expected values, assuming that the molecules investigated competed with [3H]-NMS for binding to a single site.
Ki values were determined from IC50 values, by the Cheng & Prusoff (1973) equation which assumes competitive inhibition of tracer binding to a single receptor subtype. The [3H]-NMS KD value for the three systems investigated was determined in separate experiments, as described by Waelbroeck et al. (1987a,b; . The pKi values, indicated in Table 1 We therefore estimated the standard deviation of pK; values as being of approximately 0.15 log unit (40% of Ki value).
Pharmacological studies
General considerations Guinea-pigs (300-450 g) of either sex were killed by cervical dislocation and the organs required were set up under 0.5 g tension in were conducted at pH 7.4, 320C. Arecaidine propargyl ester (Mutschler & Lambrecht, 1984; Barlow & Weston-Smith, 1985) , except where indicated, was used as the agonist. After 1 h equilibration, concentration-response curves were obtained by cumulative addition of the agonists (van Rossum, 1963) . When these responses were regular the tissues were exposed to a solution of antagonist and each concentration of antagonist was allowed to equilibrate before repeating the concentration-response curve.
Guinea-pig isolated ileum Strips of ileal longitudinal muscle (1.5 cm) were prepared according to Paton & Zar (1968) . Tissue responses were measured as isotonic contractions with an electromechanical transducer connected to a Hellige amplifier and a Rikadenki recorder. The responses were then calculated as a percentage of the maximum response obtained to arecaidine propargyl ester and plotted against the logarithm of the agonist concentration, and EC5O values were determined for the control and the antagonist shifted concentration-response curves.
Guinea-pig isolated atria Left atria were electrically paced, by use of platinum electrodes (2 Hz, 3 ms duration, supramaximal voltage). Atrial responses to the agonists were measured as changes in isometric tension, and these effects were expressed as the percentage inhibition of the force of contraction. EC50 values were determined as described for the ileum.
Antagonist affinities (pA2) Concentration-response curves were repeated in the presence of at least 3 concentrations (log interval = 0.48) of antagonists, allowing 15-45 min equilibration time. Each concentration of antagonist was tested 3 to 5 times and dose-ratios at EC50 values of agonists were calculated. These dose-ratios were pooled for each concentration of antagonist and the slope of the Arunlakshana and Schild plots were determined by linear regression using the method of least squares. pA2 values were estimated by fitting to the data the best straight line with a slope of unity (Arunlakshana & Schild, 1959; Tallarida et al., 1979) . MO, U.S.A.) . Aprotinin (Trasylol) was obtained from Bayer, Belgium. Pirenzepine was a gift of Thomae (F.R.G.) and procyclidine (5a) was kindly provided by Deutsche Wellcome (F.R.G.). Methoctramine was kindly donated by Dr C. Melchiorre, University of Bologna, Italy. Arecaidine propargyl ester was synthesized in one of our laboratories (Mutschler & Hultzsch, 1973) .
Demethyl-hexocyclium [1-cyclohexyl-1-phenyl-2-
( Cl-] were prepared according to the literature: la and 2a CH30S03 - (Zaugg et al., 1958) ; lb and 2b CH30S03- (Tacke et al., 1989) ; 3a HCl and 3b HCl (Tacke et al., 1985) ; Sb (Tacke et al., 1983; Tacke et al., 1987a) ; 6a Cl - (Murfitt, 1956) .
Synthetic chemistry N-methyl-hexahydro-diphenidol iodide [1-(4-cyclohexyl-4-hydroxy-4-phenylbutyl)-1-methylpiperidinium iodide, 4a I], N-methylhexahydro-sila-diphenidol iodide [1-(3-(cyclohexylhydroxyphenylsilyl)propyl)-1 -methylpiperidinium iodide, 4b I-], and sila-tricyclamol iodide [1-(24(cyclohexylhydroxyphenyl)silyl)ethyl) -1 -methylpyrrolidinium iodide, 6b I-] were prepared as follows: freshly distilled methyl iodide (18 mmol) was added under an atmosphere of dried nitrogen to a solution of 3a, 3b or 5b (8 mmol) in dry ethanol (50 ml). After the reaction mixture was stirred for 3 h at 30°C, dry n-pentane (75 ml (3a, 3b) and 150 ml (5b), respectively) was added, and the mixture was stirred for 1.5 h at 20°C. Thereafter, the precipitate was collected by filtration and then recrystallized from ethanol/n-pentane. (After dissolving the precipitate in dry ethanol, the fourfold (3a, 3b) and twofold (Sb) volume, respectively, of dry n-pentane was added dropwise to the solution). After drying the crystals in vacuo (because of their hygroscopic nature, the products 4b and 6b needed an especially C/Si pairs la/lb-6a/6b did not deviate significantly from results expected for competitive inhibition of tracer binding to a single receptor. Representative competition curves are shown in Figures 2 to 4 and pKi values are given in Table 1. Atropine, pirenzepine and the quaternary compounds 4a/4b and 6a/6b exhibited similar affinities for muscarinic receptors in pancreas and heart. At both receptors the following rank order of potencies was obtained: atropine > 4a/4b = 6a/ 6b > pirenzepine.
The affinities obtained for compounds la/lb. 2a/2b, 3a/3b and 5a/5b were significantly greater for receptors in pancreas as compared to receptors in heart, and the following rank orders of potencies were obtained; heart: 2a/2b > 5a/5b > 3a/3b > la/ Ib; pancreas: 2a/2b > 3a/3b > 5a/Sb > la/lb. In contrast, the pK, value obtained for methoctramine was markedly lower in the pancreas as compared to heart. 
Results
Radioligand binding studies in NB-OK 1, heart and pancreas homogenates heart and pancreas muscarinic receptors. The following rank order of potencies was obtained: 6a/6b, 2a/2b, 4a/4b > pirenzepine = Sa/5b > la/lb. The following rank order of M1 selectivities (pK. in NB-OK 1 cells vs pKi in pancreas) was obtained: pirenzepine > 6a/6b > 4a/4b > la/lb = Sa/Sb > 2a/2b. Methoctramine and 3a/3b presented a different selectivity pattern. Whereas methoctramine recognized the NB-OK 1 receptors with an affinity intermediate between its affinity for cardiac and pancreas receptors, compounds 3a/3b exhibited the same high affinity for NB-OK 1 and pancreas receptors and a much lower affinity for the receptors in the heart.
Isolated tissue experiments on atria and ileum from guinea-pig All compounds antagonized the negative inotropic effects in electrically stimulated atria and the contractions of the ileum induced by arecaidine propargyl ester or carbachol. There was a concentration-dependent parallel shift to the right of agonist concentration-response curves without either basal tension or maximum response being affected. In all experiments Schild plots were linear through the concentration range tested for each antagonist, and slopes were not significantly different from unity (P > 0.05). Thus, all compounds were apparently simple competitive antagonists in both atrial and ileal preparations. The pA2 values are shown in Table 2 .
Atropine, pirenzepine and the quaternary compounds 4a/4b and 6a/6b exhibited similar affinities for muscarinic receptors in ileum and atria. At both receptors the following rank order of potencies was obtained: atropine > 4a/4b > 6a/6b > pirenzepine.
The affinities obtained for compounds la/lb, 2a/2b, 3a/3b, and 5a/5b were significantly greater at muscarinic receptors present in the ileum than at receptors in the atria, and the following rank orders of potencies were obtained; atria: 2a/2b > Sal 5b > 3a/3b > la/lb; ileum: 2a/2b > 3a/3b > 5al 5b > la/lb.
In contrast, the pA2 value obtained for methoctramine was much lower in the ileum compared to the affinity obtained in the atria.
Discussion
This study has investigated the differences in affinity of a series of compounds structurally related to hexahydro-diphenidol (3a) and hexahydro-sila-diphenidol (3b) at muscarinic receptors. The principal conclusions we draw from these experiments are: (1) the differences in affinity values exhibited by atropine, pirenzepine, methoctramine and compounds la/lb-6a/6b and the different rank orders of anti- The numbers show the mean estimate of the value of -log affinity constant (pA2 ± s.e.), n = 9-16 experiments. ' Arecaidine propargyl ester was used as the agonist in all cases, except carbachol. b Data previously published by Lambrecht et al., (1988a,b) muscarinic potencies confirm that NB-OK 1 cells, heart and pancreas possess different muscarinic receptors of the neuronal M1, cardiac, and glandular/smooth muscle subtypes, respectively (Waelbroeck et al., 1987a,b,c) . (2) The rat heart and pancreas muscarinic binding sites are essentially similar to the muscarinic receptors mediating negative inotropic responses in guinea-pig atria and contractions in guina-pig ileum, respectively. (3) Structural variations in the hexahydro-diphenidol (3a) and hexahydro-sila-diphenidol (3b) molecules lead to new muscarinic antagonists which exhibit a different spectrum of selectivity from the parent compounds.
Comparison of binding and pharmacological experiments
Atropine, pirenzepine, methoctramine and compounds la/lb-6a/6b showed quite wide variations in their affinities for the muscarinic receptors in pancreas, ileum and heart, their pKi (Table 1) and pA2 (Table 2) values differing by three orders of magnitude. The affinities of the antagonists for muscarinic receptors in rat pancreas and in guinea-pig ileum were very similar both individually and in rank 6.0- data on rat cardiac homogenates are related to those on guinea-pig isolated atria (A), and rat pancreas homogenates with guinea-pig isolated ileum strips (A) (data from Table 1 and 2). order. A highly significant correlation was found between these values ( Figure 5 ). The affinities for muscarinic receptors in rat heart and guinea-pig atria were also strikingly similar ( Figure 5 ), but they were different from those obtained in pancreas and ileum for most antagonists. This implies that the structural demands for the antagonists made by the muscarinic binding sites in pancreas and heart, respectively, are very similar to those made by the receptors in ileum and atria, respectively.
Structure-selectivity relationships
In the course of structure-activity relationship studies of compounds of the diphenidol type, it was found that replacement of the central carbinol carbon atom by silicon increased the affinity to muscarinic receptors in guinea-pig ileum and atria up to one order of magnitude (Tacke & Zilch, 1986; Tacke & Becker, 1987) . In contrast, sila-substitution of la/6a (-.lb/6b) had little effect on the affinity in binding studies as well as in pharmacological experiments (Tables 1 and 2 ). This might be explained by differences in electronic and stereochemical properties: compounds of the diphenidol type carry two phenyl rings at the central C/Si atom, whereas in the case of la/lb-6a/6b one phenyl ring is hydrogenated to a cyclohexyl ring system. The tertiary amines demethyl-hexocyclium (Ja), procyclidine (Sa) and their silicon analogues (lb, 5b) are muscarinic antagonists that possess a different selectivity profile from the parent compounds hexahydro-diphenidol (3a) and hexahydro-sila-diphenidol (3b). The following affinity rank orders at M1, cardiac and glandular/smooth muscle receptors were obtained; 3a/3b: M1 = glandular/smooth muscle > cardiac; la/ib, Sa/5b: M1 > glandular/ smooth muscle > cardiac. N-methylation of the tertiary amines la/lb, 3a/3b and 5a/5b increased the affinity for cardiac as well as for NB-OK 1 cell M1 receptors by up to one log unit (Tables 1 and 2 ). This also holds true for la/lb (-.2a/2b) at glandular/smooth muscle receptors in ileum and pancreas, whereas the affinity for glandular/smooth muscle receptors of 3a/3b and 5a/5b was not changed or only poorly increased by N-methylation. Thus, the selectivity profiles of the quaternary compounds hexocyclium (2a) and sila-hexocyclium (2b) are identical to that of the tertiary amines la/lb (M1 > glandular/smooth muscle > cardiac), the affinities of 2a/2b being higher by about one order of magnitude than those of the tertiary compounds la/lb at the three subtypes. In contrast, N-methylation of 3a/3b (-.4a/4b) and Sa/Sb (-.6a/6b) changed the receptor selectivity patterns of the tertiary amines. The following affinity rank order was obtained; 4a/4b, 6a/6b: M1 > glandular/smooth muscle > cardiac. Thus, 4a/4b and 6a/6b show a selectivity profile that is qualitatively similar to that of pirenzepine.
In conclusion, the present study shows that on the basis of the binding profiles of pirenzepine, methoc-tramine and compounds la/lb-6a/6b the muscarinic receptors in NB-OK 1 cells, heart and pancreas can be clearly subdivided into three subtypes: M1, cardiac and glandular/smooth muscle receptors. We have provided evidence that the muscarinic binding sites in the rat heart and pancreas are very similar to guinea-pig atria and ileum receptors, respectively, but different from each other. We have shown that the antimuscarinic potency and subtype selectivity of hexahydro-diphenidol (3a) and hexahydro-sila-diphenidol (3b) and of the analogues la/lb, 2a/2b and 4a/4b-6a/6b depend on different structural parameters (e.g. tertiary or quaternary nitrogen). The M1, cardiac and glandular/smooth muscle muscarinic receptors make different structural demands for the antagonists thus different receptor selectivity profiles were obtained. Compounds la/lb-6a/6b will facilitate further investigation of muscarinic receptor heterogeneity.
